You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 155 No. 11, 12 JUNE 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (280)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nosocomial Bloodstream Infections

Secular Trends in Rates, Mortality, and Contribution to Total Hospital Deaths

Didier Pittet, MD, MS; Richard P. Wenzel, MD, MSc

Arch Intern Med. 1995;155(11):1177-1184.


Abstract

Background
Nosocomial bloodstream infections occur at a rate of 1.3 to 14.5 per 1000 hospital admissions and are believed to lead directly to 62 500 deaths per year in the United States. Measures of the incidence and the proportion of all hospital deaths related to deaths from these infections provide estimates of their impact. The objectives of the study were to characterize the secular trends in nosocomial bloodstream infection at a single institution and to estimate the population-attributable risk for death among patients experiencing the infection.

Methods
A 12-year retrospective study using prospectively collected data from a hospital-wide surveillance system for nosocomial infections in a 900-bed tertiary care institution. All patients (N=260 834) admitted to the institution between 1980 and 1992 were included in the study. Bloodstream infection rates were calculated for the 10 leading groups of pathogens, and trends were analyzed using simple linear regression. In-hospital mortality rates from patients who did or did not develop nosocomial bloodstream infections were compared.

Results
Between 1980 and 1992, a total of 3077 patients developed 3464 episodes of nosocomial bloodstream infection. The crude infection rates increased linearly from 6.7 to 18.4 per 1000 discharges (0.83 to 1.72 episodes per 1000 patient-days) during the 12-year study period (r=.87). Increases in the infection rates were due to gram-positive cocci (r=.96) and yeasts (r=.95) and essentially explained by infections caused by coagulase-negative staphylococci, Staphylococcus aureus, enterococci, and Candida species, respectively. Although the crude mortality in patients with nosocomial bloodstream infections decreased from 51% in 1981 to 29% in 1992, the in-hospital population-attributable mortality among infected patients increased from 3.55 deaths per 1000 discharges in 1981 to 6.22 per 1000 discharges in 1992 (r=.67). The etiologic fraction or the proportion of deaths in patients with bloodstream infection to all deaths occurring in the hospital increased from 11.4% in 1981 to 20.4% in 1992 (r=.59).

Conclusions
The incidence, the etiologic fraction, and the population-attributable risk for death among patients experiencing nosocomial bloodstream infections increased progressively during the last decade.

(Arch Intern Med. 1995;155:1177-1184)



Author Affiliations

From the Division of General Medicine, Clinical Epidemiology and Health Services Research, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immunological Mechanisms Underlying the Genetic Predisposition to Severe Staphylococcus aureus Infection in the Mouse Model
von Kockritz-Blickwede et al.
Am. J. Pathol. 2008;173:1657-1668.
ABSTRACT | FULL TEXT  

Analysis of base excision and nucleotide excision repair in Candida albicans
Legrand et al.
Microbiology 2008;154:2446-2456.
ABSTRACT | FULL TEXT  

Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes
Marschall et al.
J Antimicrob Chemother 2008;61:1376-1383.
ABSTRACT | FULL TEXT  

Ocular candidiasis: a review
Shah et al.
Br J Ophthalmol 2008;92:466-468.
ABSTRACT | FULL TEXT  

Resistant gram-negative bacilli: A neglected healthcare crisis?
Lautenbach and Polk
Am J Health Syst Pharm 2007;64:S3-S21.
ABSTRACT | FULL TEXT  

Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters.
Hanna et al.
Antimicrob. Agents Chemother. 2006;50:3283-3288.
ABSTRACT | FULL TEXT  

Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.
Colombo et al.
J. Clin. Microbiol. 2006;44:2816-2823.
ABSTRACT | FULL TEXT  

Reemergence of Gram-negative Health Care-Associated Bloodstream Infections.
Albrecht et al.
Arch Intern Med 2006;166:1289-1294.
ABSTRACT | FULL TEXT  

Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome
Fang et al.
J Antimicrob Chemother 2006;57:511-519.
ABSTRACT | FULL TEXT  

Frequency of Fungemia in Hospitalized Pediatric Inpatients Over 11 Years at a Tertiary Care Institution
Abelson et al.
Pediatrics 2005;116:61-67.
ABSTRACT | FULL TEXT  

Direct Identification of Major Blood Culture Pathogens, Including Pseudomonas aeruginosa and Escherichia coli, by a Panel of Fluorescence In Situ Hybridization Assays Using Peptide Nucleic Acid Probes
Sogaard et al.
J. Clin. Microbiol. 2005;43:1947-1949.
ABSTRACT | FULL TEXT  

Risk Factors for Ineffective Therapy in Patients With Bloodstream Infection
McDonald et al.
Arch Intern Med 2005;165:308-313.
ABSTRACT | FULL TEXT  

Epidemiology and Typing of Staphylococcus aureus Strains Isolated from Bloodstream Infections
van der Mee-Marquet et al.
J. Clin. Microbiol. 2004;42:5650-5657.
ABSTRACT | FULL TEXT  

Mupirocin Prophylaxis against Nosocomial Staphylococcus aureus Infections in Nonsurgical Patients: A Randomized Study
Wertheim et al.
ANN INTERN MED 2004;140:419-425.
ABSTRACT | FULL TEXT  

A RecA-LexA-dependent Pathway Mediates Ciprofloxacin-induced Fibronectin Binding in Staphylococcus aureus
Bisognano et al.
J. Biol. Chem. 2004;279:9064-9071.
ABSTRACT | FULL TEXT  

Total Parenteral Nutrition and Infections Associated With Use of Central Venous Catheters
Deshpande
Am J Crit Care 2003;12:326-327.
FULL TEXT  

Rapid Detection of Candida albicans in Clinical Blood Samples by Using a TaqMan-Based PCR Assay
Maaroufi et al.
J. Clin. Microbiol. 2003;41:3293-3298.
ABSTRACT | FULL TEXT  

Epidemiology and Prognostic Determinants of Bloodstream Infections in Surgical Intensive Care
Harbarth et al.
Arch Surg 2002;137:1353-1359.
ABSTRACT | FULL TEXT  

Guidelines for the Prevention of Intravascular Catheter-Related Infections
O'Grady et al.
Pediatrics 2002;110:e51-51.
ABSTRACT | FULL TEXT  

The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida
Safdar and Maki
ANN INTERN MED 2002;136:834-844.
ABSTRACT | FULL TEXT  

Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic Rabbits
Petraitis et al.
Antimicrob. Agents Chemother. 2002;46:1857-1869.
ABSTRACT | FULL TEXT  

Development of a P1 phagemid system for the delivery of DNA into Gram-negative bacteria
Westwater et al.
Microbiology 2002;148:943-950.
ABSTRACT | FULL TEXT  

Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected with Aspergillus Species and Other Filamentous Fungi: Maximum Tolerated Dose Study
Walsh et al.
Antimicrob. Agents Chemother. 2001;45:3487-3496.
ABSTRACT | FULL TEXT  

Infection Control in the ICU
Eggimann and Pittet
Chest 2001;120:2059-2093.
ABSTRACT | FULL TEXT  

Prospective Study of Candida Species in Patients at a Comprehensive Cancer Center
Safdar et al.
Antimicrob. Agents Chemother. 2001;45:2129-2133.
ABSTRACT | FULL TEXT  

Outcomes of Primary and Catheter-related Bacteremia . A Cohort and Case-Control Study in Critically Ill Patients
RENAUD and BRUN-BUISSON
Am. J. Respir. Crit. Care Med. 2001;163:1584-1590.
ABSTRACT | FULL TEXT  

In Vitro Resistance of Staphylococcus aureus to Thrombin-Induced Platelet Microbicidal Protein Is Associated with Alterations in Cytoplasmic Membrane Fluidity
Bayer et al.
Infect. Immun. 2000;68:3548-3553.
ABSTRACT | FULL TEXT  

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis
Reacher et al.
BMJ 2000;320:213-216.
ABSTRACT | FULL TEXT  

Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci
Entenza et al.
J Antimicrob Chemother 1999;44:775-786.
ABSTRACT | FULL TEXT  

Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial
Geddes et al.
J Antimicrob Chemother 1999;44:799-810.
ABSTRACT | FULL TEXT  

The Attributable Mortality and Costs of Primary Nosocomial Bloodstream Infections in the Intensive Care Unit
DIGIOVINE et al.
Am. J. Respir. Crit. Care Med. 1999;160:976-981.
ABSTRACT | FULL TEXT  

In Vitro Activities of Two Ketolides, HMR 3647 and HMR 3004, against Gram-Positive Bacteria
Malathum et al.
Antimicrob. Agents Chemother. 1999;43:930-936.
ABSTRACT | FULL TEXT  

Clinical, Microbial, and Biochemical Aspects of the Exfoliative Toxins Causing Staphylococcal Scalded-Skin Syndrome
Ladhani et al.
Clin. Microbiol. Rev. 1999;12:224-242.
ABSTRACT | FULL TEXT  

Impact of the High-Affinity Proline Permease Gene (putP) on the Virulence of Staphylococcus aureus in Experimental Endocarditis
Bayer et al.
Infect. Immun. 1999;67:740-744.
ABSTRACT | FULL TEXT  

In Vitro Resistance to Thrombin-Induced Platelet Microbicidal Protein among Clinical Bacteremic Isolates of Staphylococcus aureus Correlates with an Endovascular Infectious Source
Bayer et al.
Antimicrob. Agents Chemother. 1998;42:3169-3172.
ABSTRACT | FULL TEXT  

Constant Low Rate of Fungemia in Norway, 1991 to 1996
Sandven et al.
J. Clin. Microbiol. 1998;36:3455-3459.
ABSTRACT | FULL TEXT  

Safety, Tolerance, and Pharmacokinetics of a Small Unilamellar Liposomal Formulation of Amphotericin B (AmBisome) in Neutropenic Patients
Walsh et al.
Antimicrob. Agents Chemother. 1998;42:2391-2398.
ABSTRACT | FULL TEXT  

Efficacy of Trovafloxacin, a New Quinolone Antibiotic, in Experimental Staphylococcal Endocarditis Due to Oxacillin-Resistant Strains
Bayer et al.
Antimicrob. Agents Chemother. 1998;42:1837-1841.
ABSTRACT | FULL TEXT  

In Vitro Resistance to Thrombin-Induced Platelet Microbicidal Protein Is Associated with Enhanced Progression and Hematogenous Dissemination in Experimental Staphylococcus aureus Infective Endocarditis
Dhawan et al.
Infect. Immun. 1998;66:3476-3479.
ABSTRACT | FULL TEXT  

Photoaffinity Analog of the Semisynthetic Echinocandin LY303366: Identification of Echinocandin Targets in Candida albicans
Radding et al.
Antimicrob. Agents Chemother. 1998;42:1187-1194.
ABSTRACT | FULL TEXT  

Rapid Detection of Candida albicans in Clinical Samples by DNA Amplification of Common Regions from C. albicans-Secreted Aspartic Proteinase Genes
Flahaut et al.
J. Clin. Microbiol. 1998;36:395-401.
ABSTRACT | FULL TEXT  

Impact of Methicillin Resistance on the Outcome of Patients With Bacteremia Caused by Staphylococcus aureus
Harbarth et al.
Arch Intern Med 1998;158:182-189.
ABSTRACT | FULL TEXT  

Binding of Candida albicans to Immobilized Amino Acids and Bovine Serum Albumin
Hawser and Islam
Infect. Immun. 1998;66:140-144.
ABSTRACT | FULL TEXT  

Secular Trends in Nosocomial Bloodstream Infections in a 55-Bed Cardiothoracic Intensive Care Unit
Gordon et al.
Ann. Thorac. Surg. 1998;65:95-100.
ABSTRACT | FULL TEXT  

Fungal infections in critically ill patients
Lipman and Saadia
BMJ 1997;315:266-267.
FULL TEXT  

CARDIAC SURGERY IN A HIGH-RISK GROUP OF PATIENTS: IS PROLONGED POSTOPERATIVE ANTIBIOTIC PROPHYLAXIS EFFECTIVE?.
Niederhauser et al.
J. Thorac. Cardiovasc. Surg. 1997;114:162-168.
ABSTRACT | FULL TEXT  

Single-Organism Model of Host Defense against Infection: A Novel Immunotoxicologic Approach to Evaluate Immunomodulatory Drugs
Herzyk et al.
Toxicol Pathol 1997;25:351-362.
ABSTRACT  

Significance of the Isolation of Candida Species from Respiratory Samples in Critically Ill, Non-neutropenic Patients . An Immediate Postmortem Histologic Study
EL-EBIARY et al.
Am. J. Respir. Crit. Care Med. 1997;156:583-590.
ABSTRACT | FULL TEXT  

TRENDS IN NOSOCOMIAL BLOODSTREAM INFECTIONS
JWatch General 1995;1995:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.